IO Biotech (IOBT) stock rallies as cancer vaccine, Cylembio, with Merck's (MRK) Keytruda outperforms in a late-stage trial ...

After the success of the Phase Ib study, Assembly Bio’s herpes therapy will advance to Phase II trials in mid-2026.

Shares of several biotech firms fell in premarket trading Monday after reports that ousted U.S. Food and Drug Administration ...

HHS Secretary Robert F Kennedy Jr has canceled nearly $500 million in grants and contracts meant to support mRNA vaccine development.

Moderna announced July 10 that the FDA had fully approved its Spikevax COVID vaccine for kids ages 6 months through 11 years ...

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

News of a trade secrets leak involving TSMC and an action in Japan against AI startup Perplexity were also among the top ...

Termination of contracts and “de-scoping” of mRNA-related work in existing contracts, along with other changes, will affect ...

Messenger RNA vaccines, or mRNA, differ from traditional ones. Instead of growing a virus and weakening it to allow the body to engage its natural defenses, mRNA vaccines use pieces of genetic code to ...

A research project at Emory University is among the 22 grants and contracts that are being cancelled as the U.S. Department ...

In justifying the government's termination of $500 million in funding for mRNA vaccine projects, Health and Human Services ...

Modern science emerged precisely to deal with the way everything can be manipulated – and scepticism over ‘facts’ goes all ...